Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.047847 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Zexun Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Affiliated Hospital of Jiangsu University Zhenjiang China. Hauptthemen laut MEDLINE: Atherosclerosis, Energy Metabolism, Macrophages, Metabolic Reprogramming. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Atherosclerosis is a chronic inflammatory disease driven by metabolic disorders, and macrophages play a central role in their occurrence and development. Macrophages are not static; their functional polarization and fate decisions are highly regulated by metabolic signals from the microenvironment, a process known as metabolic reprogramming. This review systematically reviews the latest progress in the metabolic reprogramming of glucose, lipids, and mitochondria in atherosclerosis, focusing on how key metabolites such as glycolysis, pentose phosphate pathway, cholesterol/sphingolipid metabolism, gut microbiota derivatives, and oxaloacetate dynamically regulate the inflammatory phenotype, foam cell formation, and immune response of macrophages. This review also delves into new concepts such as trained immunity and analyzes the therapeutic potential of targeting these metabolic pathways, aiming to comprehensively reveal the core role of metabolic‐immune cross‐talk in atherosclerosis and provide a theoretical basis for developing new strategies for diagnosing and treating atherosclerosis based on macrophage metabolic reprogramming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Affiliated Hospital of Jiangsu University Zhenjiang China.
- Institute of Cardiovascular Diseases Jiangsu University Zhenjiang China.
- Department of Biochemistry and Molecular Biology Jiangsu University School of Medicine Zhenjiang China.
- Department of Pathology Affiliated Hospital of Jiangsu University Zhenjiang China.
ORCID-Profile: Zexun Wang, Ying Zhang, Lihua Li, Zhongqun Wang
Zitieren
APA
Wang, Z., Zhang, Y., Li, L., & Wang, Z. (2026). Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047847
Vancouver
Wang Z, Zhang Y, Li L, Wang Z. Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047847
BibTeX
@article{Wang2026,
author = {Wang, Zexun and Zhang, Ying and Li, Lihua and Wang, Zhongqun},
title = {Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.047847}
}
EUVIMED